CEPH Message Board - Msg: 370265

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Nelson who wrote (25)	10/19/1996 2:48:00 AM
From: Nathan L.	of 998

Hi Mark- I listened in on an interview with Chiron's CEO and he staggered out a denial of aquiring CEPH. This interview took place last week. It looks to me that someone is trimming the fat on Cephalon's businesses for a future buyout. If we are to believe that Chiron will buy Cephalon, but the buyout would result in excess manufacturing capacity, then it would seem smart to sell the plant to NVX before making the announcement. This way there is no overlap if it took place. I don't know anything about NVX's pertussis vaccine, but i do know that Chiron's vaccine has many benifits from current vaccines on the market now. On top of this, Chiron now has excellent distribution in Europe of their vaccine products through their 49% interest in Behringwerke Vaccine (now known as Chiron Behring GmbH & Co.) The plot thickens... nate.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next